Literature DB >> 10037059

Nephrotic syndrome as a clinical manifestation of graft-versus-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal.

J S Oliveira1, D Bahia, M Franco, C Balda, S Stella, J Kerbauy.   

Abstract

GVHD is one of the most frequent complications of BMT and recently nephrotic syndrome (NS) has been described as a manifestation of chronic GVHD. Here, we present an AA patient who developed NS 1 year after BMT when cyclosporine was stopped. Renal biopsy showed focal sclerosis associated with membranous deposits. He also had other clinical manifestations of chronic GVHD: sicca-like syndrome and colestasis. After 15 days of CsA therapy, he experienced a remarkable improvement in the NS and GVHD as a whole. We comment on immunological mechanisms that could be involved in the pathogenesis of this manifestation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10037059     DOI: 10.1038/sj.bmt.1701527

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  13 in total

1.  Glomerular vasculopathy after unrelated cord blood transplantation.

Authors:  Chihaya Imai; Toshio Kakihara; Haruko Iwabuchi; Atsushi Tanaka; Tatsuo Furukawa; Makoto Uchiyama
Journal:  Pediatr Nephrol       Date:  2003-03-21       Impact factor: 3.714

2.  A young woman with oedema.

Authors:  Elena Lazzeri; Giuseppe Stefano Netti; Benedetta Mazzinghi; Calogero Cirami; Maurizio Salvadori; Paola Romagnani
Journal:  Intern Emerg Med       Date:  2006       Impact factor: 3.397

3.  Nephrotic syndrome in a child after umbilical-cord-blood transplantation.

Authors:  Joo Hoon Lee; Bo Sang Kwon; Il Soo Ha; Hae Il Cheong; Kyung Chul Moon; Hyo Seop Ahn; Yong Choi
Journal:  Pediatr Nephrol       Date:  2006-06-22       Impact factor: 3.714

4.  Nephrotic syndrome with extensive mesangiolysis as a clinical manifestation of chronic graft-versus-host disease (GVHD).

Authors:  Keiki Kawakami; Yasuyuki Watanabe; Katsumi Mukai; Mikio Takagi; Tetsuya Murata; Tomoko Gotoh; Shigehisa Kitano
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

5.  NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report.

Authors:  Howard M Shulman; Diana M Cardona; Joel K Greenson; Sangeeta Hingorani; Thomas Horn; Elisabeth Huber; Andreas Kreft; Thomas Longerich; Thomas Morton; David Myerson; Victor G Prieto; Avi Rosenberg; Nathaniel Treister; Kay Washington; Mirjana Ziemer; Steven Z Pavletic; Stephanie J Lee; Mary E D Flowers; Kirk R Schultz; Madan Jagasia; Paul J Martin; Georgia B Vogelsang; David E Kleiner
Journal:  Biol Blood Marrow Transplant       Date:  2015-01-29       Impact factor: 5.742

Review 6.  Renal function following hematological stem cell transplantation in childhood.

Authors:  Ludwig Patzer; Karim Kentouche; Felix Ringelmann; Joachim Misselwitz
Journal:  Pediatr Nephrol       Date:  2003-04-29       Impact factor: 3.714

7.  Membranous nephropathy after allogeneic stem cell transplantation: report of 2 cases.

Authors:  Chizuko Tsutsumi; Yasushi Miyazaki; Takuya Fukushima; Shinichiro Yoshida; Jun Taguchi; Chie Miyake; Masanobu Miyazaki; Shigeru Kohno; Itsuro Jinnai; Masao Tomonaga
Journal:  Int J Hematol       Date:  2004-02       Impact factor: 2.490

8.  A boy with membranous nephropathy after allogeneic bone marrow transplantation.

Authors:  Osamu Motoyama; Yumiko Uchino; Mika Tokuyama; Kikuo Iitaka; Akira Ohara
Journal:  Clin Exp Nephrol       Date:  2009-05-09       Impact factor: 2.801

9.  Focal segmental glomerulosclerosis as a complication of graft-versus-host disease.

Authors:  Claudia Fofi; Simona Barberi; Antonella Stoppacciaro; Giorgio Punzo; Paolo Menè
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

10.  Membranous nephropathy associated with donor lymphocyte infusion following allogeneic bone marrow transplantation.

Authors:  Yasuhiko Miyazaki; Yasukiyo Mori; Noriko Kishimoto; Noriaki Matsumoto; Katsuhiro Zen; Ryuichi Amakawa; Yuji Kishimoto; Shirou Fukuhara
Journal:  Int J Hematol       Date:  2003-10       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.